BioSyent named to 2024 TSX Venture Top 50



Bringing to market innovative healthcare products to serve Canadians and their providers.

View BioSyent’s brands

people in banner
people in banner
people in banner
people in banner

About BioSyent

BioSyent is a profitable and growing specialty pharmaceutical company committed to improving the lives of patients with unique and effective products in Canada and select international markets.

Our Core Values

Integrity

We believe in the importance of open and honest communication, honouring our commitments, and ethical conduct.

Respect

We respect our co-workers, customers, business partners, vendors, and shareholders and demonstrate this respect through our actions, words, attitudes and openness to new ideas.

Leadership

Each person is accountable for our success in meeting the needs of our customers and the expectations of our shareholders and we hold ourselves personally responsible for achieving success. This attitude can be summarized as doing things right, and doing the right things.

Corporate
Sustainability

We make decisions and take action based upon the long term health and prosperity of our Company, and the maintenance of our relationships

Perseverance

We believe in steady persistence in the face of difficulties, obstacles and discouragement.

Embracing
Change

We recognize that our business and the markets we serve are dynamic, and we are committed to fostering both corporate and personal development to adapt to change.

We proudly source, in-license, acquire and further develop innovative pharmaceutical and healthcare products from around the world to fill unmet medical needs in various therapeutic areas.

Biosyent Product Logos
At a glance
Company Financials
2023
Results Webcast
Financials
Management Discussion and Analysis
Presentation Slides
2022
Results Webcast
Financials
Management Discussion and Analysis
Presentation Slides

Revenue

BioSyent Revenue Growth chart

Earnings Before Interest, Tax, Depreciation and Amortization (EBITDA)

Earnings Before Interest, Tax, Depreciation and Amortization (EBITDA)

Net Income After Tax (NIAT)

Net Income After Tax

Year Ending December 31. All funds in Canadian dollars

Recent Press Releases

Careers at BioSyent

Join our team and you could be integral to the introduction of products that address unmet medical needs in the Canadian market.

View current positions

We’re BioSyent and we’re looking for ambitious people to join our growing team. Please send your cover letter and résumé to careers@biosyent.com